non stimulant medications

The ADHD treatment landscape is evolving rapidly in 2026, offering new hope for patients across Florida who haven’t found success with traditional stimulant medications. FDA Approval of Simtriyo (Centanafadine): A Game-Changer for Florida Patients In July 2026, the FDA approved Simtriyo (centanafadine), the first-in-class norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI) for ADHD in adults […]